Novo Integrated Sciences, Inc. (NVOS) vs Syra Health Corp. (SYRA)
- Novo Integrated Sciences, Inc. NVOS 0.00 NaN
- Syra Health Corp. SYRA 0.84 0.00%
Novo Integrated Sciences, Inc. and Syra Health Corp. are both Medical Care Facilities companies. Syra Health Corp. is the larger, with a market value of $1.1M against $730.0K — 1.5× the size. Novo Integrated Sciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Syra Health Corp. trades at 84.0×. Novo Integrated Sciences, Inc. grew revenue faster over the last twelve months: 5.75% against 0.32%. Syra Health Corp. has the higher net margin (1.62% vs −121.6%) and the higher return on invested capital (9.15% vs −42.4%). Across the 15 metrics below, Syra Health Corp. leads on 11 and Novo Integrated Sciences, Inc. on 4.
Valuation
Profitability
| Metric | NVOS | SYRA | Medical Care Facilities median |
|---|---|---|---|
| Gross margin | 43.19% | 39.35% | 30.78% |
| Operating margin | (75.79%) | 0.92% | 5.74% |
| Net margin | (121.61%) | 1.62% | 2.32% |
| Free cash flow margin | (38.54%) | 1.36% | 5.46% |
| Return on equity | (82.67%) | 5.18% | 8.76% |
| Return on assets | (47.76%) | 3.58% | 2.18% |
| Return on invested capital | (42.44%) | 9.15% | 5.01% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack